155 related articles for article (PubMed ID: 22171935)
1. Economic evaluation of a 100% whey-based partially hydrolyzed infant formula in the prevention of atopic dermatitis among Swiss children.
Iskedjian M; Belli D; Farah B; Navarro V; Detzel P
J Med Econ; 2012; 15(2):378-93. PubMed ID: 22171935
[TBL] [Abstract][Full Text] [Related]
2. Economic evaluation of a 100% whey-based partially hydrolyzed infant formula in the prevention of atopic dermatitis among Danish children.
Iskedjian M; Haschke F; Farah B; van Odijk J; Berbari J; Spieldenner J
J Med Econ; 2012; 15(2):394-408. PubMed ID: 22171936
[TBL] [Abstract][Full Text] [Related]
3. Partially hydrolysed 100% whey-based infant formula and the prevention of atopic dermatitis: comparative pharmacoeconomic analyses.
Spieldenner J; Belli D; Dupont C; Haschke F; Iskedjian M; Nevot Falcó S; Szajewska H; von Berg A
Ann Nutr Metab; 2011; 59 Suppl 1():44-52. PubMed ID: 22189255
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of partially-hydrolyzed formula for prevention of atopic dermatitis in Australia.
Su J; Prescott S; Sinn J; Tang M; Smith P; Heine RG; Spieldenner J; Iskedjian M
J Med Econ; 2012; 15(6):1064-77. PubMed ID: 22630113
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of a 100% whey-based, partially hydrolysed formula in the prevention of atopic dermatitis among French children.
Iskedjian M; Dupont C; Spieldenner J; Kanny G; Raynaud F; Farah B; Haschke F
Curr Med Res Opin; 2010 Nov; 26(11):2607-26. PubMed ID: 20925454
[TBL] [Abstract][Full Text] [Related]
6. Economic value of using partially hydrolysed infant formula for risk reduction of atopic dermatitis in high-risk, not exclusively breastfed infants in Singapore.
Botteman MF; Bhanegaonkar AJ; Horodniceanu EG; Ji X; Lee BW; Shek LP; Van Bever HP; Detzel P
Singapore Med J; 2018 Aug; 59(8):439-448. PubMed ID: 29214323
[TBL] [Abstract][Full Text] [Related]
7. Economic Burden of Atopic Dermatitis in High-Risk Infants Receiving Cow's Milk or Partially Hydrolyzed 100% Whey-Based Formula.
Bhanegaonkar A; Horodniceanu EG; Ji X; Detzel P; Boguniewicz M; Chamlin S; Lake A; Czerkies LA; Botteman MF; Saavedra JM
J Pediatr; 2015 May; 166(5):1145-1151.e3. PubMed ID: 25919724
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of a partially hydrolysed 100%-whey infant formula vs. extensively hydrolysed infant formulas in the prevention of atopic dermatitis.
Iskedjian M; Szajewska H; Spieldenner J; Farah B; Berbari J
Curr Med Res Opin; 2010 Nov; 26(11):2599-606. PubMed ID: 20925453
[TBL] [Abstract][Full Text] [Related]
9. Is prevention of atopic eczema with hydrolyzed formulas cost-effective? A health economic evaluation from Germany.
Mertens J; Stock S; Lüngen M; von Berg A; Krämer U; Filipiak-Pittroff B; Heinrich J; Koletzko S; Grübl A; Wichmann HE; Bauer CP; Reinhardt D; Berdel D; Gerber A
Pediatr Allergy Immunol; 2012 Sep; 23(6):597-604. PubMed ID: 22624978
[TBL] [Abstract][Full Text] [Related]
10. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
Halken S
Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
[TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness of Partially Hydrolyzed Whey Protein Formula in the Primary Prevention of Atopic Dermatitis in At-Risk Urban Filipino Infants.
Bhanegaonkar AJ; Horodniceanu EG; Gonzalez RRH; Canlas Dizon MV; Detzel P; Erdogan-Ciftci E; Verheggen B; Botteman MF
Value Health Reg Issues; 2014 May; 3():124-135. PubMed ID: 29702918
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of the evidence for a partially hydrolyzed 100% whey formula for the prevention of allergic diseases.
Szajewska H; Horvath A
Curr Med Res Opin; 2010 Feb; 26(2):423-37. PubMed ID: 20001576
[TBL] [Abstract][Full Text] [Related]
13. Partially hydrolyzed 100% whey protein infant formula and reduced risk of atopic dermatitis: a meta-analysis.
Alexander DD; Cabana MD
J Pediatr Gastroenterol Nutr; 2010 Apr; 50(4):422-30. PubMed ID: 20216095
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of partially hydrolyzed whey protein formula in the primary prevention of atopic dermatitis in high-risk urban infants in Southeast Asia.
Botteman M; Detzel P
Ann Nutr Metab; 2015; 66 Suppl 1():26-32. PubMed ID: 25925338
[TBL] [Abstract][Full Text] [Related]
15. Allergies in high-risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10-year results from the German Infant Nutritional Intervention (GINI) study.
von Berg A; Filipiak-Pittroff B; Krämer U; Hoffmann B; Link E; Beckmann C; Hoffmann U; Reinhardt D; Grübl A; Heinrich J; Wichmann HE; Bauer CP; Koletzko S; Berdel D;
J Allergy Clin Immunol; 2013 Jun; 131(6):1565-73. PubMed ID: 23506844
[TBL] [Abstract][Full Text] [Related]
16. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three-year results of the German Infant Nutritional Intervention Study.
von Berg A; Koletzko S; Filipiak-Pittroff B; Laubereau B; Grübl A; Wichmann HE; Bauer CP; Reinhardt D; Berdel D;
J Allergy Clin Immunol; 2007 Mar; 119(3):718-25. PubMed ID: 17240440
[TBL] [Abstract][Full Text] [Related]
17. FDA's health claim review: whey-protein partially hydrolyzed infant formula and atopic dermatitis.
Chung CS; Yamini S; Trumbo PR
Pediatrics; 2012 Aug; 130(2):e408-14. PubMed ID: 22778306
[TBL] [Abstract][Full Text] [Related]
18. Modified proteins in allergy prevention.
von Berg A
Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():239-47; discussion 247-57. PubMed ID: 19710526
[TBL] [Abstract][Full Text] [Related]
19. Hypersensitivity to hydrolyzed cow's milk protein formula in infants and young children with atopic eczema/dermatitis syndrome with cow's milk protein allergy.
Kaczmarski M; Wasilewska J; Lasota M
Rocz Akad Med Bialymst; 2005; 50():274-8. PubMed ID: 16358982
[TBL] [Abstract][Full Text] [Related]
20. Partially hydrolyzed 100% whey protein infant formula and atopic dermatitis risk reduction: a systematic review of the literature.
Alexander DD; Schmitt DF; Tran NL; Barraj LM; Cushing CA
Nutr Rev; 2010 Apr; 68(4):232-45. PubMed ID: 20416019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
